<DOC>
	<DOCNO>NCT00716079</DOCNO>
	<brief_summary>The purpose academic lead study determine treatment strategy early intensive blood pressure ( BP ) lower compare conservative BP lowering policy patient elevate blood pressure within 6 hour acute intracerebral haemorrhage ( ICH ) improve outcome death disability 3 month onset .</brief_summary>
	<brief_title>The Second Intensive Blood Pressure Reduction Acute Cerebral Haemorrhage Trial</brief_title>
	<detailed_description>Intracerebral haemorrhage ( ICH ) one serious subtypes stroke , affect million people worldwide year , live Asia . About one third people ICH die early onset majority survivor leave major long-term disability . Despite magnitude disease burden cost healthcare resource , remain uncertainty role surgery ICH acute medical therapy show definitely alter outcome ICH . The INTERACT2 study follow recently complete initial pilot study vanguard phase ) establish feasibility protocol , safety early intensive BP lowering , effect haematoma expansion within 6 hour onset ICH . Having establish 'proof-of-concept ' BP lowering may improve outcome reduce haematoma expansion , INTERACT2 aim establish effect treatment major clinical endpoint patient ICH recruit expand clinical network around world .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Cerebral Hemorrhage</mesh_term>
	<mesh_term>Hydralazine</mesh_term>
	<mesh_term>Labetalol</mesh_term>
	<mesh_term>Phentolamine</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<criteria>Patients CTconfirmed spontaneous Intracerebral Haemorrhage ( ICH ) Elevated systolic blood pressure ( &gt; 150mmHg &lt; 220mmHg ) Capacity commence randomly assign treatment within 6 hour onset ICH . Able 'actively ' treat admit monitored facility Clear indication contraindication intensive BP lowering . Evidence ICH secondary structural abnormality Use thrombolytic agent Previous ischaemic stroke within 30 day A high likelihood patient die within next 24 hour basis clinical and/or radiological criterion Score 35 Glasgow Coma Scale ( indicate deep coma ) Significant prestroke disability advance dementia Planned early neurological intervention Participation another clinical trial . A high likelihood patient adhere study treatment followup regimen .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Cerebral Hemorrhage</keyword>
	<keyword>Stroke</keyword>
	<keyword>antihypertensive drug</keyword>
	<keyword>blood pressure</keyword>
	<keyword>disability</keyword>
	<keyword>clinical trial</keyword>
	<keyword>outcome</keyword>
</DOC>